Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 273

    1.

    The molecular mechanisms of arsenic-induced cell transformation and apoptosis.

    Dong Z.

    Environ Health Perspect. 2002 Oct;110 Suppl 5:757-9.PMID: 12426127 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Arsenic induces apoptosis through a c-Jun NH2-terminal kinase-dependent, p53-independent pathway.

    Huang C, Ma WY, Li J, Dong Z.

    Cancer Res. 1999 Jul 1;59(13):3053-8.PMID: 10397243 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Requirement of Erk, but not JNK, for arsenite-induced cell transformation.

    Huang C, Ma WY, Li J, Goranson A, Dong Z.

    J Biol Chem. 1999 May 21;274(21):14595-601.PMID: 10329651 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The extracellular-signal-regulated protein kinases (Erks) are required for UV-induced AP-1 activation in JB6 cells.

    Huang C, Ma WY, Dong Z.

    Oncogene. 1999 May 6;18(18):2828-35.PMID: 10362253 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Involvement of c-jun NH(2)-terminal kinases in resveratrol-induced activation of p53 and apoptosis.

    She QB, Huang C, Zhang Y, Dong Z.

    Mol Carcinog. 2002 Apr;33(4):244-50.PMID: 11933078 [PubMed - indexed for MEDLINE]Related articles

    7.

    Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase.

    She QB, Bode AM, Ma WY, Chen NY, Dong Z.

    Cancer Res. 2001 Feb 15;61(4):1604-10.PMID: 11245472 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.

    Gulati AP, Yang YM, Harter D, Mukhopadhyay A, Aggarwal BB, Benzil DL, Whysner J, Albino AP, Murali R, Jhanwar-Uniyal M.

    Mol Carcinog. 2006 Jan;45(1):26-37. Erratum in: Mol Carcinog. 2006 Jul;45(7):549. Aggarwal, Bharat A [corrected to Aggarwal, Bharat B]. PMID: 16267831 [PubMed - indexed for MEDLINE]Related articles

    9.

    Acquisition of apoptotic resistance in arsenic-induced malignant transformation: role of the JNK signal transduction pathway.

    Qu W, Bortner CD, Sakurai T, Hobson MJ, Waalkes MP.

    Carcinogenesis. 2002 Jan;23(1):151-9.PMID: 11756236 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Arsenic-induced NFkappaB transactivation through Erks- and JNKs-dependent pathways in mouse epidermal JB6 cells.

    Huang C, Li J, Ding M, Wang L, Shi X, Castranova V, Vallyathan V, Ju G, Costa M.

    Mol Cell Biochem. 2001 Jun;222(1-2):29-34.PMID: 11678607 [PubMed - indexed for MEDLINE]Related articles

    11.

    Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.

    Watts RG, Huang C, Young MR, Li JJ, Dong Z, Pennie WD, Colburn NH.

    Oncogene. 1998 Dec 31;17(26):3493-8.PMID: 10030673 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Opposed arsenite-induced signaling pathways promote cell proliferation or apoptosis in cultured lung cells.

    Lau AT, Li M, Xie R, He QY, Chiu JF.

    Carcinogenesis. 2004 Jan;25(1):21-8. Epub 2003 Sep 26.PMID: 14514659 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.

    Dhar A, Hu J, Reeves R, Resar LM, Colburn NH.

    Oncogene. 2004 May 27;23(25):4466-76.PMID: 15064752 [PubMed - indexed for MEDLINE]Related articles

    16.

    Selective induction of apoptosis in mutant p53 premalignant and malignant cancer cells by PRIMA-1 through the c-Jun-NH2-kinase pathway.

    Li Y, Mao Y, Brandt-Rauf PW, Williams AC, Fine RL.

    Mol Cancer Ther. 2005 Jun;4(6):901-9.PMID: 15956247 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    10-formyltetrahydrofolate dehydrogenase-induced c-Jun-NH2-kinase pathways diverge at the c-Jun-NH2-kinase substrate level in cells with different p53 status.

    Ghose S, Oleinik NV, Krupenko NI, Krupenko SA.

    Mol Cancer Res. 2009 Jan;7(1):99-107.PMID: 19147541 [PubMed - indexed for MEDLINE]Related articles

    18.

    Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation.

    Wang J, Ouyang W, Li J, Wei L, Ma Q, Zhang Z, Tong Q, He J, Huang C.

    Cancer Res. 2005 Aug 1;65(15):6601-11.PMID: 16061640 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    JNK activation is required for JB6 cell transformation induced by tumor necrosis factor-alpha but not by 12-O-tetradecanoylphorbol-13-acetate.

    Huang C, Li J, Ma WY, Dong Z.

    J Biol Chem. 1999 Oct 15;274(42):29672-6.PMID: 10514437 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The c-Jun NH(2)-terminal protein kinase/AP-1 pathway is required for efficient apoptosis induced by vinblastine.

    Fan M, Goodwin ME, Birrer MJ, Chambers TC.

    Cancer Res. 2001 Jun 1;61(11):4450-8.PMID: 11389075 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data